WATSON 803
Pill imprint WATSON 803 has been identified as Meclizine hydrochloride 25 mg.
Meclizine is used in the treatment of vertigo; motion sickness; nausea/vomiting and belongs to the drug class anticholinergic antiemetics. There is no proven risk in humans during pregnancy.
Meclizine 25 mg is not subject to the Controlled Substances Act.
See also related documents.
Meclizine hydrochloride Images
- Imprint:
-
WATSON 803
- Strength:
- 25 mg
- Color:
- White & Yellow
- Size:
- 13.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Rx and/or OTC
- Inactive Ingredients:
- silicon dioxide colloidal
corn starch
D&C Yellow No. 10 Lake
lactose monohydrate
microcrystalline cellulose
sodium starch glycolate
stearic acid
- Drug Class:
- Anticholinergic antiemetics
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 00591-0803
Advertisement
More Meclizine Hydrochloride resources
- Meclizine
- Meclizine (Wolters Kluwer)
- Meclizine Chewable Tablets (Wolters Kluwer)
- meclizine (Cerner Multum)
- Meclizine Hydrochloride (AHFS DI)
- Meclizine (FDA)
- Meclizine (Wolters Kluwer)
Search Again
